PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 349.50
Bid: 348.50
Ask: 350.00
Change: 2.00 (0.58%)
Spread: 1.50 (0.43%)
Open: 340.00
High: 350.00
Low: 340.00
Prev. Close: 347.50
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

12 Feb 2013 07:00

RNS Number : 6408X
Volex PLC
12 February 2013
 



12 February 2013

VOLEX plc

 

Interim Management Statement

Volex plc ('Volex' or the 'Group), the global provider of electrical, digital and optical connections, today releases its second Interim Management Statement for FY2013, covering the 19 weeks to 11 February 2013.

Group trading

Trading conditions have remained challenging, as previously reported in our 14 December 2012 update. Despite the background of macro-uncertainty and general softening of demand, we have won new business with a major global technology company. We are making good progress with our restructuring programme. Our sales and finance functions have been strengthened and are more closely aligned with our sectors. Production cost and operating expense savings are being delivered as expected. Accordingly, management expects full year revenue and operating profit* for the year ending 31 March 2013 to be in line with revised market expectations**.

Update on improvement plan

Management is focused on a number of initiatives to improve performance and consequently rebuild shareholder value. These include strengthening the senior sales leadership team and the effectiveness of our sales organisation, executing our cost reduction initiatives and accelerating the Group's move to a higher margin product portfolio. While there is still much to do we have made good progress.

Daniel Abrams joined the Company, as Chief Financial Officer on 17 December 2012. We have reorganised the sales and finance functions to better serve key accounts, improve alignment with our sectors, and strengthen our forecasting processes. We have also appointed Roger Wendelken as Senior Vice President, Sales and Marketing. Most recently Roger was SVP Worldwide Sales at SMSC prior to its acquisition by Microchip and he has also held senior sales roles at Applied Micro Circuits Corporation (AMCC), Marvell Semiconductors and IBM.

We are on track to deliver the targeted cost savings of an annualised $10m. We have also increased production efficiency and lowered scrap rates.

On 14 January 2013, the Company successfully completed the acquisition of the active optical technology platform from Applied Micro Circuits Corporation, based in California. The acquisition of a patent portfolio, technology and product designs for active optical cable (AOC) assemblies provides Volex with accelerated entry into the multi-billion dollar AOC and optical transceiver market. It represents a modest yet important step towards developing new technological capabilities to drive higher margin revenue growth.

Financial position

Net debt at 31 December 2012 was $14.8m (31 March 2012: net cash $3.6m).

 

 

Outlook

Trading conditions have remained challenging in the early part of 2013. Management expects full year revenue and operating profit* for the year ending 31 March 2013 to be in line with revised market expectations**.

- END -

Notes

* Operating profit is defined as normalised operating profit before exceptional restructuring costs and share based payment charges

** The average of analyst forecasts, updated since the trading update on 14 December 2012, is $473m in revenue and $11m in operating profit for the year ending 31 March 2013.

For further information please contact:

 

Volex plc

Ray Walsh Chief Executive Officer +44 20 3370 8830

Daniel Abrams Chief Financial Officer +44 20 3370 8830

Tulchan Communications

Christian Cowley / James Macey White +44 207 353 4200

 

 

Forward looking statements

Certain statements in this announcement are forward-looking statements which are based on Volex's expectations, intentions and projections regarding its future operating performance and objectives, anticipated events or trends and other matters that are not historical facts. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as 'anticipates', 'aims', 'could', 'may', 'should', 'expects', 'believes', 'intends', 'plans', 'targets', 'goal' or 'estimates'. By their very nature forward-looking statements are inherently unpredictable, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, by way of example only and not limited to, general economic conditions, currency fluctuations, competitive factors, the loss or failure of one or more major customers, changes in raw materials or labour costs, and issues associated with implementing our strategic plan among other risks. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, Volex undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGMZNMNGFZM
Date   Source Headline
19th Oct 20205:47 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
26th Aug 20205:02 pmRNSHolding(s) in Company
26th Aug 20208:57 amRNSDirector/PDMR Shareholding
19th Aug 20207:00 amRNSDirector/PDMR Shareholding
7th Aug 20205:06 pmRNSPDMR / PCA Dealing
5th Aug 202010:28 amRNSPDMR / PCA Dealing
30th Jul 20204:29 pmRNSCompany Secretary Change
30th Jul 20204:26 pmRNSResult of AGM
30th Jul 20207:00 amRNSAGM Statement
6th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSNotice of AGM and Annual Report and Accounts
26th Jun 20203:50 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Jun 20207:00 amRNSDirector/PDMR Shareholding
22nd Jun 20206:23 pmRNSDirector/PDMR Shareholding
18th Jun 20207:01 amRNSInvestor Presentation
18th Jun 20207:00 amRNSPreliminary Group Results FY2020
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20204:19 pmRNSDirector/PDMR Shareholding
24th Apr 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSTrading Update
6th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20201:31 pmRNSDirector/PDMR Shareholding
3rd Apr 20203:41 pmRNSDirector/PDMR Shareholding
1st Apr 20202:54 pmRNSDirector/PDMR Shareholding
30th Mar 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSChange of Registered Office
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20205:00 pmRNSDirector/PDMR Shareholding
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
11th Mar 20202:03 pmRNSHolding(s) in Company
9th Mar 20204:30 pmRNSDirector/PDMR Shareholding
6th Mar 20204:41 pmRNSSecond Price Monitoring Extn
6th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202012:07 pmRNSSecond Price Monitoring Extn
6th Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 202012:47 pmRNSDeferred Consideration for Servatron Acquisition
26th Feb 20203:49 pmRNSEBT Share Purchase
17th Feb 20207:00 amRNSStatement Regarding Situation in China - Update
13th Feb 20205:26 pmRNSEBT Share Purchase
10th Feb 20209:57 amRNSStatement Regarding Current Situation in China
15th Jan 20203:47 pmRNSHolding(s) in Company
15th Jan 20203:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.